...
search icon
krro-img

Frequency Therapeutics Inc, Common Stock

KRRO

NAQ

$15.105

-$0.61

(-3.88%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$150.06M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
6.85K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$11.13 L
$98 H
$15.105

About Frequency Therapeutics Inc, Common Stock

Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. Its lead product candidate is KRRO-110 which is in Phase 1/2 clinical trial for the treatment of Alpha-1 Antitrypsin Deficiency (AATD). It uses its RNA editing platform, Oligonucleotide Promoted Editing of RNA to generate differentiated RNA editing product candidates. The company is also developing programs for Parkinson's disease, Amyotrophic lateral sclerosis, severe drug-associated anesthetics, and other pain indications. Korro Bio, Inc. has a collaboration agreement with Novo Nordisk A/S to treat cardiometabolic diseases. Korro Bio, Inc. was founded in 2018 and is based in Cambridge, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameKRROSectorS&P500
1-Week Return-1.69%-1.17%2.03%
1-Month Return15.18%1.36%15.76%
3-Month Return-46.75%-8.22%-2.99%
6-Month Return-66.31%-4.84%0.76%
1-Year Return-71.23%-7.97%12.24%
3-Year Return-75.26%4.8%52.77%
5-Year Return-98.26%34.33%103.64%
10-Year Return-97.71%79.04%180.09%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue36.98M14.07M--2.27M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":38.04,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":6.14,"profit":true}]
Cost of Revenue1.58M3.84M2.51M3.63M3.56M[{"date":"2020-12-31","value":41.14,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":65.37,"profit":true},{"date":"2023-12-31","value":94.51,"profit":true},{"date":"2024-12-31","value":92.81,"profit":true}]
Gross Profit35.40M10.23M(2.51M)(3.63M)(1.29M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":28.89,"profit":true},{"date":"2022-12-31","value":-7.09,"profit":false},{"date":"2023-12-31","value":-10.25,"profit":false},{"date":"2024-12-31","value":-3.65,"profit":false}]
Gross Margin95.73%72.70%--(56.98%)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":75.94,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-59.52,"profit":false}]
Operating Expenses62.95M35.49M59.00M84.53M94.18M[{"date":"2020-12-31","value":66.84,"profit":true},{"date":"2021-12-31","value":37.69,"profit":true},{"date":"2022-12-31","value":62.64,"profit":true},{"date":"2023-12-31","value":89.76,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(27.55M)(35.49M)(59.00M)(84.53M)(91.91M)[{"date":"2020-12-31","value":-2755000000,"profit":false},{"date":"2021-12-31","value":-3549400000,"profit":false},{"date":"2022-12-31","value":-5899800000,"profit":false},{"date":"2023-12-31","value":-8453400000,"profit":false},{"date":"2024-12-31","value":-9191000000,"profit":false}]
Total Non-Operating Income/Expense--1.80M--[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Pre-Tax Income(26.48M)(21.96M)(58.02M)(81.14M)(83.44M)[{"date":"2020-12-31","value":-2647600000,"profit":false},{"date":"2021-12-31","value":-2195700000,"profit":false},{"date":"2022-12-31","value":-5802200000,"profit":false},{"date":"2023-12-31","value":-8114500000,"profit":false},{"date":"2024-12-31","value":-8344000000,"profit":false}]
Income Taxes35.00K2.00K10.00K27.00K141.00K[{"date":"2020-12-31","value":24.82,"profit":true},{"date":"2021-12-31","value":1.42,"profit":true},{"date":"2022-12-31","value":7.09,"profit":true},{"date":"2023-12-31","value":19.15,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes--(58.03M)--[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-5803200000,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations-(21.96M)(58.03M)(81.17M)(83.58M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-2195900000,"profit":false},{"date":"2022-12-31","value":-5803200000,"profit":false},{"date":"2023-12-31","value":-8117200000,"profit":false},{"date":"2024-12-31","value":-8358100000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(26.51M)(21.96M)(58.03M)(81.17M)(83.58M)[{"date":"2020-12-31","value":-2651100000,"profit":false},{"date":"2021-12-31","value":-2195900000,"profit":false},{"date":"2022-12-31","value":-5803200000,"profit":false},{"date":"2023-12-31","value":-8117200000,"profit":false},{"date":"2024-12-31","value":-8358100000,"profit":false}]
EPS (Diluted)(0.81)(2.47)(2.32)(42.00)(9.39)[{"date":"2020-12-31","value":-81,"profit":false},{"date":"2021-12-31","value":-247,"profit":false},{"date":"2022-12-31","value":-232,"profit":false},{"date":"2023-12-31","value":-4200,"profit":false},{"date":"2024-12-31","value":-938.87,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

KRRO
Cash Ratio 8.92
Current Ratio 9.41

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

KRRO
ROA (LTM) -29.82%
ROE (LTM) -60.22%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

KRRO
Debt Ratio Lower is generally better. Negative is bad. 0.31
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.69

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

KRRO
Trailing PE NM
Forward PE NM
P/S (TTM) 30.60
P/B 1.06
Price/FCF NM
EV/R 16.13
EV/Ebitda NM

FAQs

What is Frequency Therapeutics Inc share price today?

Frequency Therapeutics Inc (KRRO) share price today is $15.105

Can Indians buy Frequency Therapeutics Inc shares?

Yes, Indians can buy shares of Frequency Therapeutics Inc (KRRO) on Vested. To buy Frequency Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in KRRO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Frequency Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Frequency Therapeutics Inc (KRRO) via the Vested app. You can start investing in Frequency Therapeutics Inc (KRRO) with a minimum investment of $1.

How to invest in Frequency Therapeutics Inc shares from India?

You can invest in shares of Frequency Therapeutics Inc (KRRO) via Vested in three simple steps:

  • Click on Sign Up or Invest in KRRO stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Frequency Therapeutics Inc shares
What is Frequency Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Frequency Therapeutics Inc (KRRO) is $98. The 52-week low price of Frequency Therapeutics Inc (KRRO) is $11.13.

What is Frequency Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Frequency Therapeutics Inc (KRRO) is 1.06

What is the Market Cap of Frequency Therapeutics Inc?

The market capitalization of Frequency Therapeutics Inc (KRRO) is $150.06M

What is Frequency Therapeutics Inc’s stock symbol?

The stock symbol (or ticker) of Frequency Therapeutics Inc is KRRO

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top